End-to-end security testing of your device throughout the product release cycle enables you to leverage our attacker perspective to identify material security risks to your patients and organization. Collaborate with our adversarial experts to develop the necessary documentation to confidently tell your security story.

Combine attack surface management and continuous penetration testing to ensure comprehensive postmarket monitoring. Our adversarial managed service team, enabled by our continuous offensive security platform, Chariot, provides greater breadth of assessment and time-on-target than one-off penetration testing can provide. Praetorian helps you address the FDA’s postmarket monitoring requirements in the following ways:

• Monitor–Gain continuous, comprehensive, and contextual asset discovery and vulnerability monitoring when you integrate Chariot with your cloud providers, source code managers, container registries, workloads, and ci/cd pipelines.
• Identify–Save your internal team time and energy by eliminating the triage process. They can be confident that any alert from our team represents a material risk that adversarial engineers have verified as an exploitable attack path.
• Address–Validate that remediation steps were effective and operate within the guidelines of your vulnerability disclosure processes.